Attenuated effector T cells are linked to control of chronic HBV infection.
Journal
Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
received:
19
04
2024
accepted:
12
07
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
28
8
2024
Statut:
ppublish
Résumé
Hepatitis B virus (HBV)-specific CD8
Identifiants
pubmed: 39198634
doi: 10.1038/s41590-024-01928-4
pii: 10.1038/s41590-024-01928-4
doi:
Substances chimiques
Transforming Growth Factor beta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1650-1662Subventions
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : TRR 179 project no. 272983813
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : CRC 1160 project no. 256073931
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : CRC 1479 project no. 441891347
Informations de copyright
© 2024. The Author(s).
Références
World Health Organization. Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b (2024).
EASL. 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370–398 (2017).
doi: 10.1016/j.jhep.2017.03.021
Thimme, R. et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77, 68–76 (2003).
pubmed: 12477811
pmcid: 140637
doi: 10.1128/JVI.77.1.68-76.2003
Maini, M. K. et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191, 1269–1280 (2000).
pubmed: 10770795
pmcid: 2193131
doi: 10.1084/jem.191.8.1269
Webster, G. J. et al. Longitudinal analysis of CD8
pubmed: 15140968
pmcid: 415806
doi: 10.1128/JVI.78.11.5707-5719.2004
Boni, C. et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 81, 4215–4225 (2007).
pubmed: 17287266
pmcid: 1866111
doi: 10.1128/JVI.02844-06
Das, A. et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J. Exp. Med. 205, 2111–2124 (2008).
pubmed: 18695005
pmcid: 2526205
doi: 10.1084/jem.20072076
Kurktschiev, P. D. et al. Dysfunctional CD8
pubmed: 25225458
pmcid: 4172217
doi: 10.1084/jem.20131333
Schurich, A. et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep. 16, 1243–1252 (2016).
pubmed: 27452473
pmcid: 4977274
doi: 10.1016/j.celrep.2016.06.078
Fisicaro, P. et al. Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B. Nat. Med. 23, 327–336 (2017).
pubmed: 28165481
doi: 10.1038/nm.4275
Heim, K. et al. TOX defines the degree of CD8
pubmed: 33097558
doi: 10.1136/gutjnl-2020-322404
Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
pubmed: 26205583
pmcid: 4889009
doi: 10.1038/nri3862
McLane, L. M., Abdel-Hakeem, M. S. & Wherry, E. J. CD8 T cell exhaustion during chronic viral infection and cancer. Annu. Rev. Immunol. 37, 457–495 (2019).
pubmed: 30676822
doi: 10.1146/annurev-immunol-041015-055318
Bengsch, B. et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8
pubmed: 20548953
pmcid: 2883597
doi: 10.1371/journal.ppat.1000947
Alfei, F. et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature 571, 265–269 (2019).
pubmed: 31207605
doi: 10.1038/s41586-019-1326-9
Blackburn, S. D., Shin, H., Freeman, G. J. & Wherry, E. J. Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade. PNAS 105, 15016–15021 (2008).
pubmed: 18809920
pmcid: 2567485
doi: 10.1073/pnas.0801497105
Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity 45, 415–427 (2016).
pubmed: 27533016
doi: 10.1016/j.immuni.2016.07.021
Schuch, A. et al. Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8
pubmed: 30622109
doi: 10.1136/gutjnl-2018-316641
Hoogeveen, R. C. et al. Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection. Gut 68, 893–904 (2019).
pubmed: 30580250
doi: 10.1136/gutjnl-2018-316644
Winkler, F. et al. Enolase represents a metabolic checkpoint controlling the differential exhaustion programmes of hepatitis virus-specific CD8(+) T cells. Gut 72, 1971–1984 (2023).
pubmed: 37541771
doi: 10.1136/gutjnl-2022-328734
Cheng, Y. et al. Multifactorial heterogeneity of virus-specific T cells and association with the progression of human chronic hepatitis B infection. Science Immunol. 4, eaau6905 (2019).
doi: 10.1126/sciimmunol.aau6905
Aliabadi, E. et al. Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection. Gut 71, 2300–2312 (2022).
pubmed: 34702717
doi: 10.1136/gutjnl-2021-324646
Bertoletti, A. & Ferrari, C. Adaptive immunity in HBV infection. J. Hepatol. 64, S71–s83 (2016).
pubmed: 27084039
doi: 10.1016/j.jhep.2016.01.026
Herman, J. S., Sagar & Grün, D. FateID infers cell fate bias in multipotent progenitors from single-cell RNA-seq data. Nat. Methods 15, 379–386 (2018).
pubmed: 29630061
doi: 10.1038/nmeth.4662
Hensel, N. et al. Memory-like HCV-specific CD8(+) T cells retain a molecular scar after cure of chronic HCV infection. Nat. Immunol. 22, 229–239 (2021).
pubmed: 33398179
doi: 10.1038/s41590-020-00817-w
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e3529 (2021).
pubmed: 34062119
pmcid: 8238499
doi: 10.1016/j.cell.2021.04.048
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819
pmcid: 6884693
doi: 10.1038/s41592-019-0619-0
Giles, J. R. et al. Shared and distinct biological circuits in effector, memory and exhausted CD8(+) T cells revealed by temporal single-cell transcriptomics and epigenetics. Nat. Immunol. 23, 1600–1613 (2022).
pubmed: 36271148
pmcid: 10408358
doi: 10.1038/s41590-022-01338-4
Beltra, J. C. et al. Stat5 opposes the transcription factor Tox and rewires exhausted CD8(+) T cells toward durable effector-like states during chronic antigen exposure. Immunity 56, 2699–2718.e2611 (2023).
pubmed: 38091951
doi: 10.1016/j.immuni.2023.11.005
Giles, J. R. et al. Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. Immunity 55, 557–574.e557 (2022).
pubmed: 35263570
pmcid: 9214622
doi: 10.1016/j.immuni.2022.02.004
Haghverdi, L., Büttner, M., Wolf, F. A., Buettner, F. & Theis, F. J. Diffusion pseudotime robustly reconstructs lineage branching. Nat. Methods 13, 845–848 (2016).
pubmed: 27571553
doi: 10.1038/nmeth.3971
Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083–1086 (2017).
pubmed: 28991892
pmcid: 5937676
doi: 10.1038/nmeth.4463
Guan, T. et al. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8(+) T cell fates. J. Exp. Med. 215, 1153–1168 (2018).
pubmed: 29449309
pmcid: 5881466
doi: 10.1084/jem.20171352
Genshaft, A. S. et al. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients. Hepatology 78, 1525–1541 (2023).
pubmed: 37158243
Dominguez, C. X. et al. The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J. Exp. Med. 212, 2041–2056 (2015).
pubmed: 26503446
pmcid: 4647261
doi: 10.1084/jem.20150186
Omilusik, K. D. et al. Transcriptional repressor ZEB2 promotes terminal differentiation of CD8
doi: 10.1084/jem.20150194
Daniel, B. et al. Divergent clonal differentiation trajectories of T cell exhaustion. Nat. Immunol. 23, 1614–1627 (2022).
pubmed: 36289450
pmcid: 11225711
doi: 10.1038/s41590-022-01337-5
Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8, 89–95 (1998).
pubmed: 9462514
doi: 10.1016/S1074-7613(00)80461-6
Shedlock, D. J. & Shen, H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300, 337–339 (2003).
pubmed: 12690201
doi: 10.1126/science.1082305
Kolumam, G. A., Thomas, S., Thompson, L. J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637–650 (2005).
pubmed: 16129706
pmcid: 2212878
doi: 10.1084/jem.20050821
Mescher, M. F. et al. Signals required for programming effector and memory development by CD8
pubmed: 16824119
doi: 10.1111/j.0105-2896.2006.00382.x
Williams, M. A., Tyznik, A. J. & Bevan, M. J. Interleukin-2 signals during priming are required for secondary expansion of CD8
pubmed: 16778891
pmcid: 2776073
doi: 10.1038/nature04790
Joshi, N. S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281–295 (2007).
pubmed: 17723218
pmcid: 2034442
doi: 10.1016/j.immuni.2007.07.010
Ruby, C. E., Redmond, W. L., Haley, D. & Weinberg, A. D. Anti-OX40 stimulation in vivo enhances CD8
pubmed: 17183611
doi: 10.1002/eji.200636428
Khakpoor, A. et al. Spatiotemporal differences in presentation of CD8 T cell epitopes during hepatitis B virus infection. J. Virol. 93, e01457–18 (2019).
pubmed: 30518652
pmcid: 6364024
doi: 10.1128/JVI.01457-18
Wiegand, S. B. et al. Soluble immune markers in the different phases of chronic hepatitis B virus infection. Sci. Rep. 9, 14118 (2019).
pubmed: 31575964
pmcid: 6773856
doi: 10.1038/s41598-019-50729-5
Dahmani, A. & Delisle, J. S. TGF-β in T cell biology: implications for cancer immunotherapy. Cancers 10, 194 (2018).
pubmed: 29891791
pmcid: 6025055
doi: 10.3390/cancers10060194
Metropulos, A. E. & Munshi, H. G. & Principe, D.R. The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial. eBioMedicine 86, 104380 (2022).
pubmed: 36455409
pmcid: 9706619
doi: 10.1016/j.ebiom.2022.104380
Rivino, L. et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. J. Clin. Investig. 128, 668–681 (2018).
pubmed: 29309050
pmcid: 5785266
doi: 10.1172/JCI92812
Tian, Y., James Ou, J. H., Hepatitis, B. & Virus-Specific, T. Cells as a biomarker for discontinuation of nucleos(t)ide analogue therapy for chronic hepatitis B. Hepatology 69, 1342–1344 (2019).
pubmed: 30168616
doi: 10.1002/hep.30243
Collins, D. R., Gaiha, G. D. & Walker, B. D. CD8(+) T cells in HIV control, cure and prevention. Nat. Rev. Immunol. 20, 471–482 (2020).
pubmed: 32051540
pmcid: 7222980
doi: 10.1038/s41577-020-0274-9
Pallett, L. J. & Maini, M. K. Liver-resident memory T cells: life in lockdown. Semin. Immunopathol. https://doi.org/10.1007/s00281-022-00932-w (2022).
Crowell H. L., Zanotelli, V. R. T., Chevrier S., Robinson M. CATALYST: Cytometry dATa anALYSis Tools. R package version 1.15.0 https://github.com/HelenaLC/CATALYST (2020).
Hashimshony, T. et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-seq. Genome Biol. 17, 77 (2016).
pubmed: 27121950
pmcid: 4848782
doi: 10.1186/s13059-016-0938-8
Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589–595 (2010).
pubmed: 20080505
pmcid: 2828108
doi: 10.1093/bioinformatics/btp698
Baker, S. C. et al. The External RNA Controls Consortium: a progress report. Nat. Methods 2, 731–734 (2005).
pubmed: 16179916
doi: 10.1038/nmeth1005-731
Grun, D., Kester, L. & van Oudenaarden, A. Validation of noise models for single-cell transcriptomics. Nat. Methods 11, 637–640 (2014).
pubmed: 24747814
doi: 10.1038/nmeth.2930
Aizarani, N. et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572, 199–204 (2019).
pubmed: 31292543
pmcid: 6687507
doi: 10.1038/s41586-019-1373-2
Sankowski, R. et al. Mapping microglia states in the human brain through the integration of high-dimensional techniques. Nat. Neurosci. 22, 2098–2110 (2019).
pubmed: 31740814
doi: 10.1038/s41593-019-0532-y
Nusser, A. et al. Developmental dynamics of two bipotent thymic epithelial progenitor types. Nature 606, 165–171 (2022).
pubmed: 35614226
pmcid: 9159946
doi: 10.1038/s41586-022-04752-8
Grun, D. et al. De novo prediction of stem cell identity using single-cell transcriptome data. Cell Stem Cell 19, 266–277 (2016).
pubmed: 27345837
pmcid: 4985539
doi: 10.1016/j.stem.2016.05.010